IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sai Parenteral's IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Telengana and caters to Pharmaceutical sector. Arihant Capital Markets is the merchant banker of Sai Parenteral's IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2025.
Sai Parenteral's IPO posted revenues of ₹ 163.10 Cr. and PAT of ₹ 14.42 Cr. in FY25 on annualised basis.
Revenue:
₹ 163.10 Cr.
EBITDA Margin:
24.53
% 
Net Worth: ₹ 95.77 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 2.30 times
Financial results of Sai Parenteral's IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 272.23 | 268.09 | 133.96 | ||
| Net Worth | 95.77 | 76.40 | 31.48 | ||
| Total Debt | 93.95 | 118.77 | 68.53 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
163.10 | 153.76 | 96.79 | ||
EBITDA
EBITDA on annualised basis |
40.01 | 33.06 | 17.85 | ||
PAT
PAT on annualised basis |
14.42 | 8.41 | 4.37 | ||
Sai Parenteral's IPO PAT Margin is 8.84 % , ROCE (Return on Capital Employed) is 28.90 % as per latest financial. The below table shows Sai Parenteral's IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 24.53 | 21.50 | 18.44 |
| PAT Margin (%) | 8.84 | 5.47 | 4.51 |
| EPS (₹) | 5.43 | 10.54 | 6.16 |
| ROE (%) | 15.06 | 11.01 | 13.88 |
| ROCE (%) | 28.90 | 20.50 | 21.00 |
| ROA (%) | 5.30 | 3.14 | 3.26 |
| Debt to Equity | 0.98 | 1.55 | 2.18 |
The market Capitalisation of Sai Parenteral's IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sai Parenteral's IPO prospectus highlights an Return on Equity (ROE) of 15.06 % , Return on Assets (ROA) of 5.30 %, and an EBITDA Margin of 24.53 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sai Parenteral's IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sai Parenteral's IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sai Parenteral's IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sai Parenteral's IPO reported revenue of ₹ 163.10 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sai Parenteral's IPO provide insights into sales growth, market demand, and business scalability.
Sai Parenteral's recorded an EBITDA of ₹ 40.01 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sai Parenteral's Profit After Tax (PAT) is ₹ 14.42 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 163.10 Cr.
EBITDA Margin:
24.53
%
Net Worth: ₹ 95.77 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA:
[●]
Sai Parenteral's operates in Pharmaceutical and Diversified Pharmaceutical Formulations Company. The Issue is listed on BSE,NSE in Oct, 2025. Sai Parenteral's IPO size was with Issue price of .
Merchant Banker(s) of Sai Parenteral's IPO: Arihant Capital Markets Limited
Sai Parenteral's IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sai Parenteral's IPO listed at a listing price of against the offer price of .
The current market price of Sai Parenteral's is .
Why Us?
